Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Int J Neuropsychopharmacol. 2013 May 14;17(7):1095–1105. doi: 10.1017/S1461145712001320

Table 2.

Study and patient characteristics

Total samplea
N=58 041
Predominantly
child studiesb
n = 21 581
Predominantly
adolescent studiesc
N=746
p value
Study characteristics
 Number of studies 15 a 5 7
Study period (N,%) 0.92
 Median <2000 5 (35.7%) 2 (40.0%) 3 (42.7%)
 Median ≥2000 9 (64.3%) 3 (60.0%) 4 (57.1%)
Location (N,%) 0.49
 Urban 7 (58.3%) 3 (60.0%) 4 (80.0%)
 Mixed (urban and rural) 5 (41.7%) 2 (40.0%) 1 (20.0%)
Institution type (N,%) 0.34
 University-teaching institutions 7 (58.3%) 2 (50.0%) 4 (80.0%)
 Non-university/mixed institutions 5 (41.7%) 2 (50.0%) 1 (20.0%)
Setting (N,%) (13) (5) (7) 0.0034
 In-patient 6 (46.2%) 0 (0%) 6 (85.7%)
 Out-patient and mixedd 7 (53.4%) 5 (100.0%) 1 (14.3%)
Country (N,%) (15) (5) (7) 0.24
 United States 12 (80.0%) 4 (80%) 5 (71.5%)
 Europe 2 (13.3%) 0 (0%) 2 (28.6%)
 Australia 1 (6.7%) 1 (20%) 0 (0%)
Patient characteristics
Demographics
 Age (mean, s.d.) 13.4±1.7 (12) 11.6±0.9 (5) 14.6±0.7 (7) 0.0004
 White (N,%) 56.9±22.4 (10) 54.5±18.2 (2) 59.1±25.9 (7) 0.82
 Male (N,%) 67.1±10.2 (13) 68.3±11.0 (5) 66.0±11.2 (7) 0.73
Diagnosis (N,%)
 ADHD 39.1±26.2 (8) 50.6±25.4 (5) 13.1±14.0 (2) 0.12
 CD or ODD 31.5±22.3 (8) 39.5±27.5 (4) 25.8±17.7 (3) 0.49
 Bipolar spectrum disorders 24.6±15.1 (8) 20.8 (1) 26.6±17.2 (6) 0.77
SCZ-spectrum disorders 22.2±20.1 (13) 16.4±13.8 (5) 28.6±23.8 (7) 0.33
Anxiety disorders/depressive disorders 18.7±12.7 (7) 14.6±8.0 (3) 26.9±14.9 (3) 0.27
Pervasive developmental disorders 18.3±10.8 8) 18.8±21.3 (2) 20.8±6.15) 0.83
14.2±10.2 (7) 16.7±10.4 (3) 12.3±11.2 (4) 0.62

ADHD, Attention deficit-hyperactivity disorder; CD, conduct disorder; ODD, oppositional defiant disorder; SCZ, schizophrenia.

a

Not all studies contributed data to all categories and the total number of studies is larger than the sum of child and adolescent studies, as data for mean age were not available in two studies.

b

Studies in which the mean participant age was <13.0 yr.

c

Studies in which the mean participant age was ≥13.0 yr.

d

Four studies contained mixed samples, predominantly consisting of out-patients, and 3 studies contained exclusively outpatients; Number of studies contributing data is shown in parentheses.

Values shown in bold indicate significant p values.